Johannes Hermann, CTO of Frontier Medicines is an early pioneer in AI-driven drug discovery, with over a decade of leadership experience across healthcare and pharmaceuticals. At Frontier, he is building Frontier's Covalent AI platform — purpose-built AI systems powered by the company's proprietary Covalent Ground Truth (CoGT™) dataset to discover breakthrough drugs against historically undruggable targets. Previously, Johannes served as global head of Data Science at Johnson & Johnson Medical Devices Technology, integrating AI into digital surgery, patient rehabilitation, and personalized treatment. At Janssen Pharmaceuticals, he led Machine Learning and Advanced Analytics across the full pharmaceutical value chain. He began his career at Roche as a data scientist and drug designer, and holds a PhD in quantum and molecular mechanics from the University of Düsseldorf, with postgraduate work at the University of Bristol and UC San Francisco.